Christiane Ritter, PhD

Dr. Ritter is co-founder and Chief Scientific Officer at Prosperodes GmbH, and CEO of Phalanx GmbH, a subsidiary of Prosperodes. It is her goal to transform seed amplification assays of multiple proteins into a quantitative, translational biomarker panel for proteinopathies.

Dr. Ritter is a biochemist by training, with a strong background in biophysical chemistry and structural biology. She holds a Ph.D. from the Swiss Institute of Technology (ETH), worked as a postdoctoral fellow at the Salk Institute, was a group leader at the Helmholtz Centre for Infection Research and joined professor at the Technical University Braunschweig. For over 25 years, she has been working on the molecular mechanisms of protein-protein interactions underlying protein folding and misfolding and, more specifically, the formation and detection of fibrillar protein aggregates in human diseases.